URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Babak Jahromi

Concepts (252)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Subarachnoid Hemorrhage
10
2003
27
2.670
Why?
Carotid Stenosis
4
2008
48
2.190
Why?
Stroke
7
2006
134
2.170
Why?
Vasospasm, Intracranial
9
2002
10
2.090
Why?
Stents
6
2008
124
1.830
Why?
Basilar Artery
9
2001
10
1.670
Why?
Cerebral Angiography
8
2002
56
1.410
Why?
Carotid Arteries
3
2008
96
1.410
Why?
Muscle, Smooth, Vascular
4
2001
336
1.310
Why?
Balloon Occlusion
2
2008
7
0.820
Why?
Carotid Artery Diseases
3
2003
53
0.770
Why?
Endarterectomy, Carotid
3
2003
30
0.760
Why?
Intracranial Aneurysm
2
2004
20
0.750
Why?
Perfusion Imaging
1
2010
13
0.730
Why?
Blood Vessel Prosthesis
1
2010
28
0.720
Why?
Calcium
6
1992
1069
0.720
Why?
Dogs
10
2001
465
0.720
Why?
Myocytes, Smooth Muscle
2
2006
97
0.660
Why?
Evidence-Based Medicine
1
2011
197
0.660
Why?
Neurosurgical Procedures
2
2004
29
0.660
Why?
Hemostatic Techniques
1
2009
11
0.650
Why?
Subclavian Artery
1
2009
24
0.650
Why?
Thromboembolism
1
2009
37
0.640
Why?
Large-Conductance Calcium-Activated Potassium Channels
2
2004
9
0.640
Why?
Catheters, Indwelling
1
2009
69
0.620
Why?
Embolization, Therapeutic
1
2008
39
0.620
Why?
Catheterization, Central Venous
1
2009
59
0.610
Why?
Patch-Clamp Techniques
7
1999
158
0.610
Why?
Vascular Surgical Procedures
1
2008
55
0.610
Why?
Vasoconstriction
1
2008
41
0.610
Why?
Shab Potassium Channels
1
2007
2
0.600
Why?
Physician's Practice Patterns
1
2010
223
0.590
Why?
Muscle Cells
1
2007
11
0.590
Why?
Potassium
2
2006
303
0.590
Why?
Tomography, X-Ray Computed
3
2004
729
0.590
Why?
Clinical Trials as Topic
1
2011
664
0.580
Why?
Potassium Channels
2
2004
128
0.580
Why?
Hemorrhage
1
2009
173
0.570
Why?
Thrombosis
1
2008
196
0.550
Why?
Postoperative Complications
1
2010
706
0.520
Why?
Time Factors
10
1999
3047
0.510
Why?
Aged, 80 and over
7
2003
2423
0.470
Why?
Chlamydophila pneumoniae
1
2003
10
0.450
Why?
Chlamydia Infections
1
2003
22
0.450
Why?
Treatment Outcome
6
2008
2487
0.440
Why?
Aged
9
2003
6986
0.410
Why?
Hemoglobins
2
2001
92
0.390
Why?
Membrane Potentials
4
1999
338
0.380
Why?
Middle Aged
10
2003
9461
0.380
Why?
Peroxides
1
2001
17
0.370
Why?
Phosphatidylcholines
1
2001
60
0.370
Why?
Nervous System Diseases
2
2011
141
0.350
Why?
Disease Models, Animal
7
2003
908
0.350
Why?
Humans
18
2001
35000
0.330
Why?
Pyramidal Cells
1
1999
25
0.320
Why?
Animals
17
1992
15647
0.320
Why?
Risk Assessment
3
2010
808
0.310
Why?
Intracellular Membranes
2
1992
74
0.290
Why?
Action Potentials
1
1999
248
0.280
Why?
Schwann Cells
2
1992
42
0.280
Why?
Male
11
1999
18870
0.260
Why?
Potassium Channels, Inwardly Rectifying
2
2004
23
0.250
Why?
Cohort Studies
2
2003
912
0.230
Why?
Female
12
2002
19061
0.220
Why?
Brain
3
1999
1161
0.220
Why?
Nitric Oxide Donors
2
2002
21
0.210
Why?
Muscle, Smooth
3
2006
102
0.210
Why?
Neurotransmitter Agents
1
1992
42
0.200
Why?
Neurosciences
1
2012
7
0.200
Why?
Carotid Artery Thrombosis
2
2008
9
0.200
Why?
Electric Stimulation
2
1992
213
0.200
Why?
Specialization
1
2012
44
0.190
Why?
STAT3 Transcription Factor
1
2011
35
0.190
Why?
Follow-Up Studies
2
2003
1757
0.190
Why?
Critical Care
1
2012
64
0.190
Why?
Synapses
1
1992
104
0.190
Why?
Kinetics
2
1999
1377
0.190
Why?
Meningeal Neoplasms
1
2011
46
0.180
Why?
Meningioma
1
2011
52
0.180
Why?
Markov Chains
1
2010
40
0.180
Why?
Cell Proliferation
2
2008
480
0.180
Why?
Neurology
1
2012
82
0.180
Why?
Health Resources
1
2010
17
0.180
Why?
Hospital Costs
1
2010
32
0.170
Why?
RNA, Messenger
5
2004
1791
0.170
Why?
Inpatients
1
2010
69
0.170
Why?
Cost-Benefit Analysis
1
2010
200
0.170
Why?
Angiography, Digital Subtraction
1
2009
23
0.160
Why?
Thrombolytic Therapy
2
2006
65
0.160
Why?
Device Removal
1
2009
29
0.160
Why?
Organ Culture Techniques
2
2006
98
0.160
Why?
Cerebral Revascularization
1
2009
3
0.160
Why?
Punctures
1
2009
25
0.160
Why?
Radiography, Interventional
1
2009
28
0.160
Why?
Intracranial Embolism
1
2009
8
0.160
Why?
Magnetic Resonance Angiography
1
2009
35
0.160
Why?
Cells, Cultured
2
2001
2367
0.160
Why?
Aorta, Thoracic
1
2009
72
0.160
Why?
Survival Rate
1
2010
584
0.160
Why?
Prevalence
1
2010
530
0.150
Why?
RNA, Ribosomal, 18S
1
2008
4
0.150
Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2008
14
0.150
Why?
Fatal Outcome
1
2008
101
0.150
Why?
Survival Analysis
1
2010
575
0.150
Why?
Decompression, Surgical
1
2008
35
0.150
Why?
Catheterization
1
2009
122
0.150
Why?
Electric Conductivity
1
2008
85
0.150
Why?
Feasibility Studies
1
2008
189
0.150
Why?
Heparin
1
2009
116
0.150
Why?
Diffusion Magnetic Resonance Imaging
1
2009
64
0.150
Why?
Reoperation
1
2008
182
0.150
Why?
Prostheses and Implants
1
2008
82
0.150
Why?
Blotting, Western
2
2004
617
0.150
Why?
Random Allocation
1
2008
245
0.150
Why?
Dose-Response Relationship, Radiation
1
2008
205
0.150
Why?
Models, Cardiovascular
1
2008
67
0.150
Why?
Anticoagulants
1
2009
128
0.150
Why?
Angioplasty, Balloon
1
2008
66
0.150
Why?
Immunohistochemistry
2
2006
1024
0.140
Why?
Endothelin-1
1
2007
24
0.140
Why?
Risk Factors
2
2010
2172
0.140
Why?
Actins
1
2008
184
0.140
Why?
Micromanipulation
1
2006
18
0.130
Why?
Isometric Contraction
1
2006
47
0.130
Why?
United States
2
2010
2511
0.130
Why?
Infarction, Middle Cerebral Artery
1
2006
16
0.130
Why?
Cyclic GMP
2
2002
70
0.130
Why?
Transducers
1
2006
39
0.130
Why?
Tissue Plasminogen Activator
1
2006
50
0.130
Why?
Adult
6
2002
10906
0.130
Why?
Retrospective Studies
2
2008
2167
0.130
Why?
Gene Expression Regulation
2
2007
848
0.130
Why?
Fibrinolytic Agents
1
2006
59
0.130
Why?
Neuromuscular Junction
2
1992
33
0.120
Why?
Calcium Channels
1
2006
164
0.120
Why?
Intracranial Thrombosis
1
2004
2
0.120
Why?
Aneurysm, Dissecting
1
2004
19
0.120
Why?
Intracranial Arteriovenous Malformations
1
2004
12
0.120
Why?
Jugular Veins
1
2004
24
0.120
Why?
Magnesium Sulfate
1
2004
10
0.110
Why?
Carotid Artery, Common
1
2004
29
0.110
Why?
Potassium Channels, Voltage-Gated
1
2004
34
0.110
Why?
Triazenes
1
2003
2
0.110
Why?
Ion Channels
1
2004
149
0.110
Why?
Blood Vessels
1
2004
89
0.110
Why?
Neuroprotective Agents
1
2004
113
0.100
Why?
Magnetic Resonance Imaging
1
2008
928
0.100
Why?
Protein S Deficiency
1
2002
5
0.100
Why?
Nitroprusside
1
2002
32
0.100
Why?
Central Nervous System Vascular Malformations
1
2002
5
0.100
Why?
Craniotomy
1
2002
16
0.100
Why?
Astrocytoma
1
2002
26
0.100
Why?
Inferior Colliculi
1
2002
32
0.100
Why?
Cyclic AMP
1
2003
224
0.100
Why?
Predictive Value of Tests
1
2003
579
0.100
Why?
Dose-Response Relationship, Drug
2
2001
1085
0.100
Why?
Osmolar Concentration
1
2001
153
0.090
Why?
Brain Neoplasms
1
2002
254
0.080
Why?
Buffers
1
1999
36
0.080
Why?
Macaca fascicularis
3
2002
81
0.080
Why?
Angioplasty
2
2009
31
0.080
Why?
Egtazic Acid
1
1999
54
0.080
Why?
Chelating Agents
1
1999
65
0.080
Why?
Dendrites
1
1999
43
0.080
Why?
Coloring Agents
1
1999
52
0.080
Why?
Rats, Wistar
1
1999
148
0.080
Why?
Muscarinic Antagonists
1
1997
11
0.070
Why?
Receptors, Muscarinic
1
1997
30
0.070
Why?
Acetylcholine
1
1997
67
0.070
Why?
Rana pipiens
2
1992
19
0.070
Why?
Barium
2
2006
16
0.070
Why?
Coronary Vasospasm
2
2004
8
0.070
Why?
Young Adult
2
2009
1013
0.060
Why?
Rats
2
1999
4185
0.060
Why?
Blood Pressure
2
2004
446
0.050
Why?
MAP Kinase Kinase 2
1
2011
5
0.050
Why?
Inhibitor of Apoptosis Proteins
1
2011
9
0.050
Why?
MAP Kinase Kinase 1
1
2011
21
0.050
Why?
TOR Serine-Threonine Kinases
1
2011
29
0.050
Why?
Proto-Oncogene Proteins c-sis
1
2011
21
0.050
Why?
Retinoblastoma Protein
1
2011
35
0.050
Why?
Caspase 3
1
2011
86
0.050
Why?
Mitogen-Activated Protein Kinase 3
1
2011
87
0.050
Why?
Adolescent
2
2009
4513
0.050
Why?
Platelet-Derived Growth Factor
1
2011
105
0.050
Why?
Mitogen-Activated Protein Kinase 1
1
2011
90
0.050
Why?
Health Surveys
1
2012
198
0.050
Why?
Immunoblotting
1
2011
210
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2011
114
0.050
Why?
Databases as Topic
1
2010
32
0.040
Why?
DNA Replication
1
2011
189
0.040
Why?
Severity of Illness Index
2
2003
878
0.040
Why?
Thrombectomy
1
2009
15
0.040
Why?
Chi-Square Distribution
1
2010
320
0.040
Why?
Odds Ratio
1
2010
301
0.040
Why?
Length of Stay
1
2010
284
0.040
Why?
Phosphorylation
1
2011
754
0.040
Why?
Intraoperative Complications
1
2009
55
0.040
Why?
Carotid Artery, Internal
1
2008
28
0.040
Why?
Disease Management
1
2008
26
0.040
Why?
Connective Tissue
1
2008
43
0.040
Why?
Proliferating Cell Nuclear Antigen
1
2008
48
0.040
Why?
Tunica Media
1
2008
27
0.040
Why?
Blood Flow Velocity
1
2008
124
0.040
Why?
Logistic Models
1
2010
581
0.040
Why?
Indoles
1
2008
93
0.040
Why?
TRPC Cation Channels
1
2007
4
0.040
Why?
Antibodies, Monoclonal
1
2011
725
0.040
Why?
Angiography
1
2007
89
0.040
Why?
Age Factors
1
2010
1060
0.030
Why?
Electrophysiology
1
2007
243
0.030
Why?
Infusions, Intra-Arterial
1
2006
15
0.030
Why?
Equipment Failure Analysis
1
2006
68
0.030
Why?
Infusions, Intravenous
1
2006
139
0.030
Why?
Stress, Mechanical
1
2006
210
0.030
Why?
Equipment Design
1
2006
244
0.030
Why?
Echoencephalography
1
2004
8
0.030
Why?
Ultrasonography, Doppler, Transcranial
1
2004
12
0.030
Why?
Single-Blind Method
1
2004
114
0.030
Why?
Arteriovenous Shunt, Surgical
1
2004
16
0.030
Why?
Delayed Rectifier Potassium Channels
1
2004
10
0.030
Why?
Potassium Channels, Calcium-Activated
1
2004
11
0.030
Why?
Sensitivity and Specificity
1
2007
866
0.030
Why?
Gene Targeting
1
2004
69
0.030
Why?
Amino Acid Sequence
1
2007
1198
0.030
Why?
Regional Blood Flow
1
2004
178
0.030
Why?
Calcium Channels, L-Type
1
2004
49
0.030
Why?
Middle Cerebral Artery
1
2003
6
0.030
Why?
Cisterna Magna
1
2002
4
0.030
Why?
Base Sequence
1
2007
1681
0.030
Why?
Signal Transduction
1
2011
1465
0.030
Why?
Injections
1
2002
63
0.030
Why?
Cerebral Arteries
1
2002
36
0.030
Why?
Treatment Failure
1
2002
125
0.030
Why?
Molecular Sequence Data
1
2007
1993
0.020
Why?
Up-Regulation
1
2004
344
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
513
0.020
Why?
Rats, Sprague-Dawley
1
2004
956
0.020
Why?
Prospective Studies
1
2004
1606
0.020
Why?
Muscarine
1
1997
2
0.020
Why?
Nicotinic Antagonists
1
1997
5
0.020
Why?
Gallamine Triethiodide
1
1997
5
0.020
Why?
Nicotinic Agonists
1
1997
7
0.020
Why?
Xanthenes
1
1997
12
0.020
Why?
Aniline Compounds
1
1997
22
0.020
Why?
Muscarinic Agonists
1
1997
20
0.020
Why?
Pertussis Toxin
1
1997
47
0.020
Why?
Virulence Factors, Bordetella
1
1997
49
0.020
Why?
Nicotine
1
1997
28
0.020
Why?
Adenosine
1
1997
86
0.020
Why?
Fluorescent Dyes
1
1997
218
0.020
Why?
Microscopy, Fluorescence
1
1997
257
0.020
Why?

Visualizations


Jahromi's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department